Stopping GLP-1 Medications: What to Expect After Treatment

Dr Shanker Pasupathy

Senior Consultant Surgeon

MBBS (Singapore), FRCS (Glasgow), FRCS (Edinburgh), FAMS (General Surgery)

After months of taking GLP-1 medications such as Ozempic, Wegovy or Mounjaro, you may have noticed changes in your appetite, eating habits and weight. But what happens when you decide to stop? Whether it is due to side effects, ongoing costs or other personal circumstances, discontinuing these medications can raise concerns about whether the progress you have made will last.

GLP-1 medications work by influencing the body's appetite and blood sugar regulation. Once treatment stops, some of these effects gradually wear off, potentially leading to increased hunger, weight regain and other changes. However, the extent of these changes varies from person to person. Knowing what to expect after stopping GLP-1 medications, and what steps may help manage the transition, is important for planning your long-term weight management.

What Happens to Your Body After Stopping GLP-1 Medications?

GLP-1 medications help regulate appetite, slow stomach emptying and influence blood sugar levels. However, these effects gradually diminish once treatment is discontinued. As the medication clears from the body, you may experience several changes:

• Increased appetite and hunger: As the appetite-suppressing effects wear off, you may feel hungry more frequently, experience stronger food cravings or find it harder to feel satisfied with smaller portions.
• Changes in blood sugar levels: Blood glucose levels may rise after stopping treatment, particularly in people with Type 2 diabetes who rely on these medications for glycaemic control.
• Potential weight regain: The return of appetite and changes in food intake may contribute to weight regain over time, although the extent varies between individuals.
• Reduced gastrointestinal side effects: Medication-related symptoms such as nausea, constipation and abdominal discomfort may gradually improve after discontinuation.

These changes do not necessarily occur immediately. For example, semaglutide (Ozempic and Wegovy) may remain in circulation for approximately 5–7 weeks after the final dose, while tirzepatide (Mounjaro) is generally eliminated more quickly.

The timing and severity of these effects vary depending on the medication, dosage and individual response. As such, stopping GLP-1 medications should be discussed with your prescribing doctor, particularly if you are also managing Type 2 diabetes.

Why Is Weight Regain Common After Stopping GLP-1 Medications?

Weight regain is one of the main concerns after discontinuing GLP-1 medications. While these treatments can help reduce appetite and food intake, they do not permanently change the body's underlying mechanisms for regulating weight. Once treatment stops, the return of hunger and other biological responses can make maintaining weight loss more challenging.

What Does Research Say About Weight Regain?

Clinical studies suggest that weight regain is common after stopping GLP-1-based treatments, although the amount regained varies between individuals and medications.

• Semaglutide (Ozempic and Wegovy): A 2022 study found that participants regained approximately two-thirds of the weight they had previously lost within one year of stopping semaglutide 2.4 mg.
• Tirzepatide (Mounjaro): In the SURMOUNT-4 trial, participants who switched from tirzepatide to a placebo experienced an average weight increase of approximately 14% over the following 52 weeks, despite having lost weight during initial treatment.

These findings highlight why GLP-1 medications are often considered part of long-term weight management rather than a temporary solution.

Does Everyone Regain Weight After Stopping GLP-1 Medications?

Not necessarily. Although weight regain is common, it does not occur to the same extent in everyone. Several factors may influence how much weight returns, including:

• Eating habits: Returning to larger portions or frequent snacking may increase calorie intake.
• Physical activity: Regular exercise can support weight maintenance and help preserve muscle mass.
• Individual biology: Differences in appetite regulation, metabolism and hormonal responses can affect weight regain.
• Ongoing support: Nutritional guidance, behavioural strategies and medical follow-up may help patients manage their weight after discontinuation.

Importantly, regaining weight does not necessarily mean the medication was ineffective. Obesity is a chronic condition influenced by biological, behavioural and environmental factors, and maintaining weight loss often requires continued management even after initial treatment goals have been achieved.

How Can You Maintain Weight Loss After Stopping GLP-1 Medications?

Although weight regain is common after discontinuing GLP-1 medications, it is not inevitable. Maintaining weight loss may become more challenging as appetite returns, but a combination of lifestyle adjustments, medical follow-up and appropriate weight management strategies can help reduce the risk.

Maintain Sustainable Eating Habits

As hunger levels increase, maintaining a balanced diet becomes particularly important. Rather than relying on restrictive diets, focus on eating habits that can be sustained over time, such as:

• Including protein-rich foods to support muscle maintenance and promote fullness.
• Choosing fibre-rich foods, including vegetables, fruits and whole grains.
• Maintaining regular meal patterns and being mindful of portion sizes.
• Limiting frequent consumption of energy-dense, nutrient-poor foods.

Stay Physically Active

Regular physical activity can help support weight maintenance, preserve muscle mass and improve metabolic health. A combination of aerobic activities, such as brisk walking or swimming, and resistance training may be beneficial.

The type and intensity of exercise should be adjusted according to your fitness level, health conditions and physical capabilities.

Continue Medical Monitoring and Follow-Up

Weight management does not necessarily end when medication is discontinued. Regular follow-up appointments allow your doctor to monitor weight changes, assess blood sugar levels where appropriate and identify early signs of weight regain.

If maintaining weight loss becomes difficult, your doctor may discuss whether restarting medication, adjusting treatment or exploring other approaches would be suitable.

Consider Alternative Weight Management Treatments

For individuals who struggle with weight regain or prefer not to rely on long-term injections, exploring the differences between weight loss surgery and injections may help clarify the available options.

One option is endoscopic sleeve gastroplasty (ESG), a minimally invasive procedure that reduces stomach capacity using endoscopic sutures without removing stomach tissue. Unlike GLP-1 medications, ESG does not routinely require ongoing weight loss injections to maintain its anatomical effects, offering a different approach to long-term weight management.

For those concerned about weight regain after stopping GLP-1 medications, ESG may be worth exploring as part of a longer-term weight management strategy.

Plan Your Long-Term Weight Management With Dr Shanker

GLP-1 medications can support weight loss, but maintaining those results after discontinuation can present new challenges. As appetite returns and the medication's effects wear off, the habits and strategies that worked during treatment may no longer be enough. Rather than viewing weight regain as inevitable, it is worth considering how your weight management approach can evolve to support lasting progress, whether through lifestyle adjustments, continued medical care or alternative treatments.

At Digestive Centre, Dr Shanker Pasupathy helps patients explore weight management options tailored to their health needs and long-term goals. For those concerned about relying on ongoing injections, endoscopic sleeve gastroplasty (ESG) may offer an alternative worth considering. Schedule a consultation to learn more about your options and discuss a suitable approach to managing your weight over time.

FAQs About Stopping GLP-1 Weight Loss Medications

Can you stop taking GLP-1 medications suddenly?

GLP-1 medications generally do not require gradual dose reduction to prevent withdrawal. However, stopping treatment abruptly may lead to a return of appetite or changes in blood sugar levels. Always discuss discontinuation with your prescribing doctor, particularly if you have Type 2 diabetes or take other glucose-lowering medications.

Do GLP-1 medications cause withdrawal symptoms?

GLP-1 medications are not generally associated with a recognised physical withdrawal syndrome. However, some people experience increased hunger, stronger food cravings or changes in blood sugar regulation as the medication's effects wear off. These changes reflect the loss of the medication's therapeutic effects rather than withdrawal in the conventional sense.

Will you regain all the weight you lost after stopping GLP-1 medications?

Not necessarily. Although studies show that weight regain is common after discontinuation, the amount varies between individuals. Some people maintain part of their weight loss, while others regain a substantial proportion. Eating habits, physical activity, individual biology and continued weight management support can influence long-term outcomes.

Can you restart GLP-1 medications after stopping them?

In some cases, GLP-1 medications can be restarted after a treatment break. However, depending on how long treatment was interrupted, your doctor may recommend restarting at a lower dose to reduce gastrointestinal side effects. The appropriate approach depends on the medication, previous dosage, treatment response and individual medical circumstances.

Can you maintain weight loss without GLP-1 medications?

Yes, some individuals can maintain weight loss after discontinuing GLP-1 medications, although doing so may be challenging. Sustainable dietary habits, regular physical activity and ongoing medical support can help. For suitable patients, alternative treatments such as endoscopic sleeve gastroplasty (ESG) may also be considered as part of a longer-term weight management plan.

Meet Our Doctor

Dr Shanker Pasupathy

Upper Gastrointestinal & Bariatric Surgeon

MBBS, National University of Singapore

Fellow of the Royal College of Surgeons (Glasgow)

Fellow of the Royal College of Surgeons (Edinburgh)

Dr Shanker Pasupathy has extensive international training in gastrointestinal endoscopy, laparoscopy and robotic surgery, with experience gained in the UK, France and Germany. Previously, he led the metabolic-bariatric surgery service at Singapore General Hospital as Director of the LIFE Centre and Senior Consultant. He remains actively involved in regional surgical training and was awarded the Dean’s Award for teaching excellence by NUS Medicine, reflecting his longstanding commitment to advancing surgical practice and medical education.

More About Dr Shanker